Literature DB >> 27548047

Hedonic and motivational responses to food reward are unchanged in rats with neuropathic pain.

Alec Okun1,2, David L McKinzie2, Jeffrey M Witkin2, Bethany Remeniuk1, Omar Husein2, Scott D Gleason2, Janice Oyarzo1, Edita Navratilova1, Brian McElroy3, Stephen Cowen3, Jeffrey D Kennedy2, Frank Porreca1.   

Abstract

Rewards influence responses to acute painful stimuli, but the relationship of chronic pain to hedonic or motivational aspects of reward is not well understood. We independently evaluated hedonic qualities of sweet or bitter tastants and motivation to seek food reward in rats with experimental neuropathic pain induced by L5/6 spinal nerve ligation. Hedonic response was measured by implantation of intraoral catheters to allow passive delivery of liquid solutions, and "liking/disliking" responses were scored according to a facial reactivity scale. Spinal nerve ligation rats did not differ from controls in either "liking" or "disliking" reactions to intraoral sucrose or quinine, respectively, at postsurgery day 21, suggesting no differences in perceived hedonic value of sweet or bitter tastants. To assess possible motivational deficits during acute and chronic pain, we used fixed- and progressive-ratio response paradigms of sucrose pellet presentation in rats with transient inflammatory or chronic neuropathic pain. Assessment of response acquisition and break points under the progressive ratio schedule revealed no differences between sham and spinal nerve ligation rats for up to 120 days after injury. However, rats with inflammation showed decrements in lever pressing and break points on days 1 and 2 after complete Freund adjuvant injection that normalized by day 4, consistent with transient ongoing pain. Thus, although acute ongoing inflammatory pain may transiently reduce reward motivation, we did not detect influences of chronic neuropathic pain on hedonic or motivational responses to food rewards. Adaptations that allow normal reward responding to food regardless of chronic pain may be of evolutionary benefit to promote survival.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27548047      PMCID: PMC5108682          DOI: 10.1097/j.pain.0000000000000695

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   7.926


  46 in total

1.  Increased taste intensity perception exhibited by patients with chronic back pain.

Authors:  Dana M Small; Vania A Apkarian
Journal:  Pain       Date:  2005-12-19       Impact factor: 6.961

Review 2.  Reward and motivation in pain and pain relief.

Authors:  Edita Navratilova; Frank Porreca
Journal:  Nat Neurosci       Date:  2014-09-25       Impact factor: 24.884

3.  The need for a new medical model: a challenge for biomedicine.

Authors:  G L Engel
Journal:  Science       Date:  1977-04-08       Impact factor: 47.728

Review 4.  Measuring hedonic impact in animals and infants: microstructure of affective taste reactivity patterns.

Authors:  K C Berridge
Journal:  Neurosci Biobehav Rev       Date:  2000-03       Impact factor: 8.989

Review 5.  A common neurobiology for pain and pleasure.

Authors:  Siri Leknes; Irene Tracey
Journal:  Nat Rev Neurosci       Date:  2008-04       Impact factor: 34.870

6.  Chronic pain. Decreased motivation during chronic pain requires long-term depression in the nucleus accumbens.

Authors:  Neil Schwartz; Paul Temkin; Sandra Jurado; Byung Kook Lim; Boris D Heifets; Jai S Polepalli; Robert C Malenka
Journal:  Science       Date:  2014-08-01       Impact factor: 47.728

7.  The Nottingham Health Profile as a measure of quality of life in zoster patients: convergent and discriminant validity.

Authors:  J Mauskopf; R Austin; L Dix; R Berzon
Journal:  Qual Life Res       Date:  1994-12       Impact factor: 4.147

8.  Differential roles of hippocampal glutamatergic receptors in neuropathic anxiety-like behavior after partial sciatic nerve ligation in rats.

Authors:  Xue-Qin Wang; Xiao-Lin Zhong; Zhi-Bin Li; Hong-Tao Wang; Juan Zhang; Fang Li; Jian-Yi Zhang; Ru-Ping Dai; Zhou Xin-Fu; Chang-Qi Li; Zhi-Yuan Li; Fang-Fang Bi
Journal:  BMC Neurosci       Date:  2015-03-14       Impact factor: 3.288

9.  Experimental gastritis leads to anxiety- and depression-like behaviors in female but not male rats.

Authors:  Jia Luo; Tao Wang; Shan Liang; Xu Hu; Wei Li; Feng Jin
Journal:  Behav Brain Funct       Date:  2013-12-17       Impact factor: 3.759

10.  Reward responsiveness in patients with chronic pain.

Authors:  N A Elvemo; N I Landrø; P C Borchgrevink; A K Håberg
Journal:  Eur J Pain       Date:  2015-03-12       Impact factor: 3.931

View more
  20 in total

Review 1.  Corticolimbic circuitry in the modulation of chronic pain and substance abuse.

Authors:  Anna M W Taylor
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-05-10       Impact factor: 5.067

2.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

3.  Attenuated dopamine receptor signaling in nucleus accumbens core in a rat model of chemically-induced neuropathy.

Authors:  Dana E Selley; Matthew F Lazenka; Laura J Sim-Selley; Julie R Secor McVoy; David N Potter; Elena H Chartoff; William A Carlezon; S Stevens Negus
Journal:  Neuropharmacology       Date:  2020-01-07       Impact factor: 5.250

4.  The α2,3-selective potentiator of GABAA receptors, KRM-II-81, reduces nociceptive-associated behaviors induced by formalin and spinal nerve ligation in rats.

Authors:  J M Witkin; R Cerne; P G Davis; K B Freeman; J M do Carmo; J K Rowlett; K R Methuku; A Okun; S D Gleason; X Li; M J Krambis; M Poe; G Li; J M Schkeryantz; R Jahan; L Yang; W Guo; L K Golani; W H Anderson; J T Catlow; T M Jones; F Porreca; J L Smith; K L Knopp; J M Cook
Journal:  Pharmacol Biochem Behav       Date:  2019-02-27       Impact factor: 3.533

5.  Pain-Induced Negative Affect Is Mediated via Recruitment of The Nucleus Accumbens Kappa Opioid System.

Authors:  Nicolas Massaly; Bryan A Copits; Adrianne R Wilson-Poe; Lucia Hipólito; Tamara Markovic; Hye Jean Yoon; Shiwei Liu; Marie C Walicki; Dionnet L Bhatti; Sunil Sirohi; Amanda Klaas; Brendan M Walker; Rachael Neve; Catherine M Cahill; Kooresh I Shoghi; Robert W Gereau; Jordan G McCall; Ream Al-Hasani; Michael R Bruchas; Jose A Morón
Journal:  Neuron       Date:  2019-03-13       Impact factor: 17.173

Review 6.  Neuropathic pain.

Authors:  Luana Colloca; Taylor Ludman; Didier Bouhassira; Ralf Baron; Anthony H Dickenson; David Yarnitsky; Roy Freeman; Andrea Truini; Nadine Attal; Nanna B Finnerup; Christopher Eccleston; Eija Kalso; David L Bennett; Robert H Dworkin; Srinivasa N Raja
Journal:  Nat Rev Dis Primers       Date:  2017-02-16       Impact factor: 52.329

7.  Behavioral outcomes of complete Freund adjuvant-induced inflammatory pain in the rodent hind paw: a systematic review and meta-analysis.

Authors:  Dominika J Burek; Nicolas Massaly; Hye Jean Yoon; Michelle Doering; Jose A Morón
Journal:  Pain       Date:  2022-05-01       Impact factor: 7.926

8.  Acute pain-related depression of operant responding maintained by social interaction or food in male and female rats.

Authors:  A N Baldwin; M L Banks; S A Marsh; E A Townsend; M Venniro; Y Shaham; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2022-01-19       Impact factor: 4.530

Review 9.  Reward, motivation, and emotion of pain and its relief.

Authors:  Frank Porreca; Edita Navratilova
Journal:  Pain       Date:  2017-04       Impact factor: 7.926

10.  Comparison of chemotherapy effects on mechanical sensitivity and food-maintained operant responding in male and female rats.

Authors:  Luke P Legakis; Clare M Diester; Edward A Townsend; Ladan Karim-Nejad; Sidney Stevens Negus
Journal:  Behav Pharmacol       Date:  2020-08       Impact factor: 2.277

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.